The page below is a sample from the LabCE course Pharmacology in the Clinical Lab: Therapeutic Drug Monitoring and Pharmacogenomics. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Pharmacology in the Clinical Lab: Therapeutic Drug Monitoring and Pharmacogenomics (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 97 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

TDM For All Drugs?

Can all drugs benefit from TDM? Not really. For TDM to be effective and useful, one or more of the following should apply:

  • The effective concentration and toxic concentrations must be well-defined.
  • The pharmacokinetics of the drug are known to be variable.
  • The drug is given chronically.
  • There is the potential for drug-to-drug interactions.
  • The drug exhibits high protein binding.
  • The toxicity will mimic the indication for the drug; toxicity may not be visible during an exam but will only be revealed with TDM.
  • The patient is pregnant, very young, or elderly.
  • Compliance or history with the drug is poor.

Unless criteria like these exist, it doesn't make much sense to perform TDM testing. Penicillin, for example is never measured in the serum. It has a wide therapeutic window, it is not given chronically, it has minimal toxicity, etc.